Position in ADCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$72,300
-$128,143 QoQ
Shares Held
19,280
-66.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. ADCT ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
216,322 | $16,408,023 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
570,032 | $13,640,865 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
202,116 | $10,447,376 | |
| 4 | ALKS |
Alkermes plc.
|
204,324 | $7,224,896 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
52,303 | $2,518,389 | |
| 6 | PRGO |
PERRIGO Co plc
|
190,050 | $2,041,137 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
161,700 | $2,009,931 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
190,058 | $1,809,352 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $72,300 | 19,280 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $200,443 | 56,783 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $183,764 | 45,941 | Shares | Sole | 2025-11-14 | |
| 2022-09-30 | $1,780,440 | 369,386 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,106,576 | 139,192 | Shares | Sole | 2022-08-22 | |
| 2020-09-30 | $2,692,775 | 81,624 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $815,664 | 17,425 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||